An Assessment of Cognitive Dysfunction among COPD Patients

Title: An Assessment of Cognitive Dysfunction among COPD Patients

Authors: Dr Aashutosh Asati, Dr Manoj Indurkar, Dr Shubhangi Nayak

DOI: https://dx.doi.org/10.18535/jmscr/v4i11.50

Abstract

References

Corresponding Author

Abstract

Introduction: The brain, in particular, may be vulnerable to the systemic effects of COPD. Cognitive dysfunction is associated with increased mortality and disability; however, it remains poorly understood in COPD. The hypoxemia seen in some patients with COPD seems to be a crucial factor for cognitive impairment, because it affects the oxygen dependent enzymes that are important in the synthesis of neurotransmitters such as acetylcholine.

Methods and Material: 40 COPD patients were subjected to SMMSE questionnaire, and then statistical analysis were conducted between their FEV1 and SMMSE questionnaire score, and between MMRC dyspnea scale score and SMMSE score.

Results: Mild cognitive impairment was found in COPD patients and there was significant positive correlation was found between SMMSE score with FEV1, and significant negative correlation between SMMSE score and MMRC score.

Conclusion: Cognitive impairment was significantly correlated with severity of disease in COPD patients. For early identification of cognitive dysfunction of COPD patients by SMMSE will defiantly helpful to physician to assess the cognitive function.

References

1. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121:789–796.

2. Rodriguez Gonzalez-Moro JM, de Lucas Ramos P, Izquierdo Alonso JL, et al. Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies. Int J Clin Pract. 2009;63:742–750.

3. Thakur N, Blanc PD, Julian LJ. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. International Journal of Chronic Obstructive Pulmonary Disease 2010;5:263-9.

4. Duong T, Acton PJ, Johnson RA, et al. The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions. Brain Research 1998;813:303–312.

5. Warnberg J, Gomez-Martinez S, Romeo J, et al. Nutrition, inflammation, and cognitive function. Ann N Y Acad Sci 2009;1153:164–175.

6. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183-92.

7. Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982;142:1470–1476.

8. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004;62:920–924.

9. Fletcher EC. Chronic lung disease in the sleep apnea syndrome. Lung 1990;168: Suppl.:751–761.

10. Beebe DW, Groesz L, Wells C, et al. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep 2003;26:298–307.

11. Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.

12. Corsonello A, Pedone C, Carosella L, Corica F, Mezzei B, Incalzi RA. Health status in older hospitalized patients with cancer or non-neoplastic chronic diseases. BMC Geriatr 2005;5:10.

13. Molloy W. Standardized Mini-Mental State Examination, A User’s Guide 1999;14:102-5.

14. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, et al Principi Standardized Mini-Mental State Examination Use and interpretation. Can Fam Physician 2001;47:2018-23.

15. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(2):134–137.

16. Torres SI, Rodríguez AE, Cabrera MI, López TI, Moreno MP, Valenza MC. Cognitive impairment in COPD: a systematic review. Jornal Brasileiro de Pneumologia 2015;4:182-190.

17. López TI, Torres SI, Martín SA, Ortiz RA, Rodríguez AE, Valenza MC. Cognitive impairment, nutritional status and clinical profile in chronic obstructive pulmonary disease. Nutr Hos. 2014;30:1152-9.

18. Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142(6):1516–1523.

19. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Online). Updated 2015. Available at: http://www.goldcopd.org/ uploads/ users/files/GOLD.

20. Soler-Cataluña JJ, Martínez-García MÁ, Sánchez LS, Tordera MP, Sánchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692–699.

21. Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006;130(6):1687–1694.

22. Antonelli-Incalzi R, Corsonello A, Pedone C, Corica F, Carbonin P, Bernabei R. Construct validity of activities of daily living scale: a clue to distinguish the disabling effects of COPD and congestive heart failure. Chest. 2005;127(3):830–838.

23. Fix AJ, Daughton D, Kass I, Bell CW, Golden CJ. Cognitive functioning and survival among patients with chronic obstructive pulmonary disease. Int J Neurosci. 1985;27(1–2):13–17.

24. Negro RWD, Bonadima L, Bricolo FP, Tognella S, Turco P. Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT).Multidisciplinary Respiratory Medicine201510:17.

Abstract

References

Corresponding Author

Call For Paper Volume 12 Issue 10 November 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles

Search